Levocetirizine Dihydrochloride Brillpharma (Ireland) (Levocetirizine Dihydrochloride)

The drug works by selectively antagonising peripheral histamine H1 receptors. By blocking histamine binding, it prevents the cascade that leads to vasodilation, increased vascular permeability, and sensory nerve activation, thereby reducing the typical signs of an allergic response.

The appropriate dose is determined by the prescribing clinician based on the patient’s age, condition severity, renal function, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety in pregnancy and lactation has not been definitively established. Healthcare providers should evaluate the potential benefits against any possible risks before prescribing to pregnant or nursing women, and patients should discuss their situation with a qualified professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levocetirizine is the active enantiomer of cetirizine, offering similar efficacy with a potentially lower incidence of sedation. Compared with first‑generation antihistamines, it has reduced central nervous system penetration, resulting in fewer drowsy side‑effects while maintaining strong H1‑receptor blockade.

The product should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. No refrigeration is required for this oral formulation.

Levocetirizine Dihydrochloride is taken orally, usually as a tablet or similar solid dosage form, with or without food as directed by the prescriber. The tablet should be swallowed whole with a glass of water.

Serious risks, although rare, include angioedema, severe skin reactions such as Stevens‑Johnson syndrome, and anaphylaxis. Patients should seek immediate medical attention if they experience swelling of the face or throat, widespread rash, or signs of an allergic reaction.

Individuals with known hypersensitivity to levocetirizine, cetirizine, or any component of the formulation should avoid the drug. Caution is also advised for patients with severe renal impairment, as dose adjustment may be required, and for those taking interacting medications.